ICD-10-CM Billable Code

C69.6

Malignant neoplasm of orbit

Clinical Classification Guidelines

Inclusion Terms

  • Malignant neoplasm of connective tissue of orbit
  • Malignant neoplasm of extraocular muscle
  • Malignant neoplasm of peripheral nerves of orbit
  • Malignant neoplasm of retrobulbar tissue
  • Malignant neoplasm of retro-ocular tissue

Excludes Type 1

  • malignant neoplasm of orbital bone (C41.0)

Medical Intelligence & Overview

Malignant neoplasm of the orbit refers to a cancerous growth occurring within the eye socket, known medically as the orbit. This type of tumor can originate from various tissues within the orbit, including connective tissue, muscles, nerves, or other surrounding structures. Due to its location and potential to affect vision and eye function, understanding this condition is vital for early recognition and management.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal cell growth Previous radiation exposure in the area History of cancer elsewhere spreading to the orbit Rarely, inherited genetic conditions that predispose to cancer

Key Symptoms: Visible swelling or a lump in or around the eye Protrusion of the eye (proptosis) Changes in vision, such as blurred or double vision Eye pain or discomfort Diplopia (double vision) Restricted eye movement Persistent eye redness or inflammation Loss of vision in the affected eye

Diagnostic & Treatment

Diagnosis Path: Detailed eye examination to check visual acuity, eye movements, and appearance Imaging tests such as MRI (Magnetic Resonance Imaging) or CT (Computed Tomography) scans to determine the tumor's size and extent Biopsy procedures to obtain tissue samples for pathological analysis Additional tests like ultrasound or PET scans may be used to assess spread

Treatment Protocols: Surgical removal of the tumor, which may involve excising part of the orbit or affected tissues Radiation therapy to shrink or eliminate cancer cells Chemotherapy, especially if the tumor has spread or is of specific types Targeted therapies or immunotherapy may be considered depending on the specific cancer subtype Supportive care to preserve vision and eye function whenever possible

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C69.6 a billable ICD-10 code?
Yes, C69.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C69.6?
Clinical documentation must specify the nature of Malignant neoplasm of orbit and any associated comorbidities for accurate reporting.

Cite this Clinical Reference